Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Learn how to develop, plan, and implement an organization-wide ECHO model to fully integrate HIV/HCV care and treatment into primary care centers and create wider access for patients with less barriers to care.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023
This session will discuss the implementation, outcomes, and future directions associated with the Health Services Center, Inc. Behavioral Health Co-location (BHC) Project. HSC is the sole provider of free HIV and Hepatitis C (HCV) services to a population facing multiple barriers to care (e.g., poverty, education and stigma) in a largely rural 14-county area of northeast Alabama.
Resource (Conference Presentation) updated 09/14/2023
Boston Healthcare for the Homeless Program will share its innovative approach toward the micro-elimination of Hepatitis C (HCV) for homeless-experienced people with HIV. Team members will share data around cure rates, reinfection, and engaging with marginalized patients, and discuss leveraging existing Ryan White infrastructure and resources for such efforts.
Resource (Conference Presentation) updated 09/14/2023
Panelists will describe collaborative prevention and support services provided to people with HIV and/or hepatitis from incarceration to re-entry. Services addressing social determinants of health are provided in corrections facilities and upon release. Panelists include the program director, staff from a correctional medical facility, and community-based organizations working inside and outside of correction facilities.
Resource (Conference Presentation) updated 09/14/2023
This session will help recipient and subrecipient sites to successfully connect their CAREWare and other electronic health information systems with external sources of data to report and monitor HIV care and treatment outcomes. This session will provide practical examples of successful data integration and highlight ongoing issues and costs in long-term management and maintenance.
Resource (Conference Presentation) updated 09/14/2023
The presentation will describe how CAREWare and eligibility integration eased access to services by clients in our jurisdictions. Presenters will be to provide Ryan White jurisdictions with actionable ideas and processes to integrate their CAREWare and eligibility processes to improve access to services, reporting, monitoring, and quality management.
Resource (Conference Presentation) updated 09/14/2023
The Marketplace Open Enrollment period lasts only six weeks in most states, and RWHAP programs face challenges in ensuring eligible clients are enrolled or renew their coverage. Participants will gain new strategies for creating effective enrollment partnerships as well as how to prepare staff, partners, and clients for Open Enrollment.
Resource (Conference Presentation) updated 09/14/2023
Ending the HIV Epidemic: A Plan for America provides an incredible opportunity for jurisdictions to assess their health systems, prevention activities, and linkage to care programs. It is important that health departments create innovative programs and examine how this initiative can be used to address viral hepatitis as well.
Resource (Conference Presentation) updated 09/14/2023
Explore how to leverage data visualizations created in Tableau in order to increase clinician access to HIV quality data and thereby motivating provider teams to improve quality measures. The session will also discuss an antiretroviral treatment (ART) dashboard created in Tableau.
Resource (Conference Presentation) updated 09/14/2023
CAREWare users can provide input on all CAREWare 6 software components, including ease of use, design, reports, and other features. This session will address challenges with specific features like setup, administration, generating reports, and basic data entry.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023